Somatostatin-Producing Neuroendocrine Tumor

Somatostatin-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–17 of 17 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01824875	Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors	active not recruiting	Phase 2	144	ECOG-ACRIN Cancer Research GroupNETWORK	1	Feb 25, 2026	clinicaltrials
NCT00655655	Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors	completed	Phase 1	96	Mayo ClinicOTHER	1	Aug 21, 2024	clinicaltrials
NCT01525082	Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors	completed	Phase 2	20	Shaheen ShaguftaOTHER	1	Feb 6, 2024	clinicaltrials
NCT02031536	Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

Data updated 22 days agoSource updated Feb 25, 2026source: clinicaltrials